Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering.

Macroporous beta tricalcium phosphate (beta-TCP) scaffolds were evaluated as potential carriers and delivery systems for bone morphogenetic protein-2 (BMP-2). Chemical etching was performed to increase the available surface and thus the protein loading. X-ray diffraction and infrared spectrocopy analyses confirmed the preparation of pure beta-TCP scaffolds. Scanning electron microscopy revealed interconnected porosity (64%) and a microporous surface after chemical etching. Scaffolds loaded with 30 and 15 microg of BMP-2 were implanted respectively into the back muscles and into femoral defects (condyle and diaphysis) of rabbits for 4 weeks. Histological observations confirmed the activity of the BMP-2 released from the scaffolds. Intramuscularly, bone was formed within the BMP-2-loaded scaffold pores. In the bone defects, the effect of released BMP-2 was similarly noticeable, as evaluated by histomorphometry. The incorporation of BMP-2 resulted in an amount of newly formed bone that was 1.3 times higher than with unloaded scaffolds. The implant site, however, did not have an effect on bone formation as no statistical differences were measured between cortical (diaphysis) and trabecular (condyle) defects. These results indicate the suitability of chemically etched beta-TCP scaffolds as BMP-2 carriers, in the context of bone regeneration.

[1]  Hideki Yoshikawa,et al.  Circulating Bone Marrow‐Derived Osteoblast Progenitor Cells Are Recruited to the Bone‐Forming Site by the CXCR4/Stromal Cell‐Derived Factor‐1 Pathway , 2008, Stem cells.

[2]  T. Damron,et al.  Use of 3D β-tricalcium phosphate (Vitoss®) scaffolds in repairing bone defects , 2007 .

[3]  D. Hak The Use of Osteoconductive Bone Graft Substitutes in Orthopaedic Trauma , 2007, The Journal of the American Academy of Orthopaedic Surgeons.

[4]  I Harvey,et al.  Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. , 2007, Health technology assessment.

[5]  R. Zellweger,et al.  BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.

[6]  Clemens A van Blitterswijk,et al.  Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics , 2006, International journal of nanomedicine.

[7]  S. Bidic,et al.  rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. , 2006, The Journal of bone and joint surgery. American volume.

[8]  U. Ripamonti Soluble osteogenic molecular signals and the induction of bone formation. , 2006, Biomaterials.

[9]  Huipin Yuan,et al.  3D microenvironment as essential element for osteoinduction by biomaterials. , 2005, Biomaterials.

[10]  G. Daculsi,et al.  Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. , 2005, Bone.

[11]  E. Hunziker,et al.  BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. , 2005, Bone.

[12]  J. Wozney,et al.  Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. , 2005, Journal of periodontology.

[13]  G. Daculsi,et al.  Small-animal models for testing macroporous ceramic bone substitutes. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  H. Seeherman,et al.  Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. , 2004, The Journal of bone and joint surgery. American volume.

[15]  Pierre Layrolle,et al.  Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. , 2004, Tissue engineering.

[16]  A. Sano,et al.  Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation. , 2004, International journal of pharmaceutics.

[17]  E. Hunziker,et al.  Biomimetic Coatings vs. Collagen Sponges as a Carrier for BMP-2: A Comparison of the Osteogenic Responses Triggered In Vivo Using an Ectopic Rat Model , 2003 .

[18]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[19]  Y. Tabata,et al.  Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.

[20]  P. Layrolle,et al.  Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio. , 2003, Tissue engineering.

[21]  W. Liao,et al.  [Osteogenic potential of three kinds of calcium phosphate ceramics as carriers for recombinant human morphogenetic protein-2 in vivo]. , 2003, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.

[22]  Huipin Yuan,et al.  A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats , 2002, Journal of materials science. Materials in medicine.

[23]  A. Mayes,et al.  Polymer--calcium phosphate cement composites for bone substitutes. , 2002, Journal of biomedical materials research.

[24]  Pierre Layrolle,et al.  Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering. , 2002, Journal of biomedical materials research.

[25]  M. Bohner Physical and chemical aspects of calcium phosphates used in spinal surgery , 2001, European Spine Journal.

[26]  K. de Groot,et al.  Material-dependent bone induction by calcium phosphate ceramics: a 2.5-year study in dog. , 2001, Biomaterials.

[27]  C. V. van Blitterswijk,et al.  Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier , 2001, Journal of materials science. Materials in medicine.

[28]  I. Asahina,et al.  Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. , 2001, Biomaterials.

[29]  C. Kirker-Head,et al.  Potential applications and delivery strategies for bone morphogenetic proteins. , 2000, Advanced drug delivery reviews.

[30]  J. Wozney,et al.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. , 2000, Journal of biomedical materials research.

[31]  P. Chakravarthy,et al.  alpha-BSM: a biomimetic bone substitute and drug delivery vehicle. , 1999, Clinical orthopaedics and related research.

[32]  X. Marchandise,et al.  Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. , 1999, Bone.

[33]  S. Cook Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. , 1999, Orthopedics.

[34]  K. Anselme,et al.  Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. , 1998, Journal of biomedical materials research.

[35]  Xing‐dong Zhang,et al.  Bone morphogenetic protein and ceramic-induced osteogenesis , 1998, Journal of materials science. Materials in medicine.

[36]  Hollinger,et al.  Sustained release emphasizing recombinant human bone morphogenetic protein-2. , 1998, Advanced drug delivery reviews.

[37]  I. Ishikawa,et al.  Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). , 1997, Journal of medical and dental sciences.

[38]  W. Tong,et al.  Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. , 1996, Biomaterials.

[39]  A. Reddi,et al.  Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. , 1992, Plastic and reconstructive surgery.

[40]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[41]  U. Ripamonti Bone induction in nonhuman primates. An experimental study on the baboon. , 1991, Clinical orthopaedics and related research.

[42]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N Passuti,et al.  Macroporous calcium phosphate ceramic performance in human spine fusion. , 1989, Clinical orthopaedics and related research.

[44]  K. deGroot Hydroxylapatite coated implants. , 1989 .

[45]  B Kerebel,et al.  Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. , 1989, Journal of biomedical materials research.

[46]  G. Daculsi,et al.  Crystal dissolution of biological and ceramic apatites , 1989, Calcified Tissue International.

[47]  J O Hollinger,et al.  The critical size defect as an experimental model for craniomandibulofacial nonunions. , 1986, Clinical orthopaedics and related research.

[48]  E. Dawson,et al.  Beta-tricalcium phosphate delivery system for bone morphogenetic protein. , 1984, Clinical orthopaedics and related research.

[49]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Michael Jarcho,et al.  Calcium phosphate ceramics as hard tissue prosthetics. , 1981, Clinical orthopaedics and related research.

[51]  M. Urist,et al.  Bone Morphogenetic Protein , 1971, Journal of dental research.

[52]  T. Damron Use of 3D beta-tricalcium phosphate (Vitoss) scaffolds in repairing bone defects. , 2007, Nanomedicine.

[53]  G. Daculsi,et al.  Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics , 2007, Calcified Tissue International.

[54]  J. de Groot Carriers that concentrate native bone morphogenetic protein in vivo. , 1998, Tissue engineering.

[55]  J. Hollinger,et al.  Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. , 1996, Biomaterials.

[56]  U. Ripamonti Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. , 1996, Biomaterials.

[57]  K. Leong,et al.  Poly(α-hydroxy acids). Carriers for bone morphogenetic proteins , 1996 .

[58]  X. Zhang,et al.  Osseous substance formation induced in porous calcium phosphate ceramics in soft tissues. , 1994, Biomaterials.